Research & KnowledgeEvent: September 3, 2026
CELLSCRIPT developed the Min Immunome RNA deaminator to reduce dsRNA to less than 0.005% using standard lab equipment.
Published
Signal category
Research & Knowledge
Quote
“The 𝗠𝗶𝗻-𝗜𝗺𝗺𝘂𝗻𝗲™ 𝗚𝗼𝗹𝗱 𝗱𝘀𝗥𝗡𝗔 𝗥𝗲𝗺𝗼𝘃𝗮𝗹 𝗞𝗶𝘁 uses a novel enzymatic approach to reduce dsRNA to <0.005% using standard lab equipment”
— CELLSCRIPT team
Company
CELLSCRIPT
RNA for Translation in Cells
- Industry
- Biotechnology Research
- Location
- Madison, US
- Company size
- 40 employees
CELLSCRIPT™ provides products and technologies for making and using RNA for translation in cells for clinical research and therapeutics, including RNA comprising pseudouridine (Ψ) and other modified nucleosides covered by patents licensed from the University of Pennsylvania. Products include enzymes and kits for in vitro transcription, co-transcriptional or post-transcriptional 5’ RNA capping, and 3’ RNA polyadenylation.
Founded 2007